FDA Guidance: Use of Real-World Evidence in Regulatory Decision-Making

Summary

The FDA has finalized guidance on the use of real-world data and real-world evidence to support regulatory decisions for drugs and biologics. Addresses data quality standards, study design considerations, and appropriate use cases including post-marketing requirements and label expansions.